Login  |  Register

Live Stats

AbbVie's rheumatoid arthritis drug succeeds in trial | …

AbbVie Inc said on Wednesday its oral rheumatoid arthritis drug succeeded in a late-stage study on patients who had not adequately responded to standard treatments.

Alexa Traffic